A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This study is a two-part study. Part one is designed to see how different formulations of GSK364735 are absorbed in the body and To see how food affects how GSK364735 is absorbed in the body. Part two is designed to see how repeat dosing affects how GSK364735 is absorbed in the body.
Condition or disease
HIV InfectionInfection, Human Immunodeficiency Virus
A Single Dose, Randomized, 5-Period, Balanced, Crossover Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK364735 and Pharmacokinetics Following a Double Blind, Placebo Controlled, Repeat Dose Administration to Healthy Subjects.
Study Start Date
Resource links provided by the National Library of Medicine
Part 1: PK parameters Day 1: AUC(0-t), AUC(0-t), Cmax, and C12 and C24 Part 2: PK parameters on Day 6: AUC(0-t), Ct, and Cmax
Secondary Outcome Measures
Part 1 and 2 safety measures: AE, Clinical labs, con meds, ECGs, and Vital signs Part 1: PK parameters Day 1: tmax, t1/2, tlag and CL/F Part 2: PK parameters Day 1&6: AUC 0-t, AUC 0-infinity, AUC 0-12, Cmax, C12 or C24, tmax, t1/2, CL/F, and tlag.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 55 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
The subject is healthy with no clinically significant problems identified by the physician.
Females of non-childbearing potential and males surgically sterile or agrees to birth control.
Body mass Index (BMI) of 19-29.9 (kg/m2).
As a result of the physical examination, lab results the Investigator considers the subject unfit for the study.
Blood pressure and electrocardiogram is not normal
A history of alcohol or illicit drug abuse.
Tobacco use within 3 months.
Positive for Hepatitis B surface antigen, Hepatitis C antibody or HIV antibody.
Current use of prescription or non-prescription drugs, including vitamins, herbal and dietary supplements.
Has participated in a clinical trial within 30 days prior to the first dose of study medication.